|
Market Closed -
Toronto S.E.
14:34:25 2026-10-26 EDT
|
5-day change | 1st Jan Change | ||
| 16.61 CAD | -2.01% |
|
-1.07% | +30.48% |
| 10-18 | BioSyent Inc.(TSXV:RX) added to S&P/TSX Venture Composite Index | CI |
| 09-11 | BioSyent Inc., Q2 2026 Earnings Call, Aug 20, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOSYENT INC. | Other Pharmaceuticals | -2.01% | -1.07% | +30.48% | +48.30% | +142.84% | 137M |  |  | |
- Stock Market
- Stocks
- RX Stock
- Charts BioSyent Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
